Hsinchu, Taiwan

Shiaw-Min Hwang

This inventor holds 9 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Food Industry Research and Development Institute, Ejia Biotechnology Co., Ltd., Everfront Biotech Inc.. Active years: 2003-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shiaw-Min Hwang. Retrieved from https://idiyas.com/inventor/shiaw-min-hwang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 100.0



Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2003-2020

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations of Shiaw-Min Hwang

Introduction

Shiaw-Min Hwang is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that promote health and well-being. With a total of nine patents to his name, Hwang's work focuses on innovative methods and compositions that address critical health issues.

Latest Patents

One of Hwang's latest patents involves the use of butylidenephthalide (Bdph). This invention discloses a method for utilizing Bdph and a process for preparing a pharmaceutical composition containing it. Bdph has demonstrated the ability to promote hair growth and reduce the levels of beta-amyloid protein (Aβ) in nerve cells. This capability is particularly relevant for improving the health and appearance of individuals. The invention highlights Bdph's potential in preventing or treating neurodegenerative diseases, such as Alzheimer's disease, which is associated with the accumulation of Aβ in cells. Additionally, Bdph serves as an active ingredient in topical compositions that effectively promote hair growth at the application site. The preparation method for the pharmaceutical composition involves an organic synthesis reaction, where Bdph is coated with a polymeric material, such as F127, through covalent bonding. This process aims to reduce the cytotoxicity of the pharmaceutical composition for organisms.

Career Highlights

Hwang has worked with prominent organizations, including the Food Industry Research and Development Institute and Everfront Biotech Inc. His experience in these institutions has contributed to his expertise in pharmaceutical innovations and research.

Collaborations

Some of Hwang's notable coworkers include Hing-Yuen Chan and Jian-Chyi Chen. Their collaborative efforts have likely enhanced the development and application of Hwang's inventions.

Conclusion

Shiaw-Min Hwang's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving health outcomes. His work with butylidenephthalide showcases the potential for advancements in treating neurodegenerative diseases and promoting hair growth. Hwang's career reflects a dedication to research and development that continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…